ASX - By Stock
|
IBX |
Re:
Ann: Imagion to develop nanocrystals for treating breast cancer
|
|
Oz88
|
92 |
32K |
8 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
92
|
32K
|
8
|
|
ASX - By Stock
|
IBX |
Re:
To whoever has a crystal ball?
|
|
Oz88
|
38 |
11K |
0 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
38
|
11K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
To whoever has a crystal ball?
|
|
Oz88
|
38 |
11K |
1 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
38
|
11K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interim Results
|
|
Oz88
|
49 |
16K |
0 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
An open question to IBX management
|
|
Oz88
|
71 |
20K |
0 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
71
|
20K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Interim Results
|
|
Oz88
|
49 |
16K |
0 |
31/07/21 |
31/07/21 |
ASX - By Stock
|
49
|
16K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
Oz88
|
1.7K |
605K |
1 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
1.7K
|
605K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
Oz88
|
1.7K |
605K |
0 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
1.7K
|
605K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
Oz88
|
1.7K |
605K |
2 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
1.7K
|
605K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
Oz88
|
5.5K |
1.9M |
0 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
Oz88
|
529 |
180K |
1 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
529
|
180K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Full size deoxymab PAT-DX3 crosses the blood brain barrier
|
|
Oz88
|
82 |
29K |
0 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
82
|
29K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
Oz88
|
529 |
180K |
0 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
529
|
180K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Full size deoxymab PAT-DX3 crosses the blood brain barrier
|
|
Oz88
|
82 |
29K |
0 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
82
|
29K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
Oz88
|
529 |
180K |
4 |
11/07/21 |
11/07/21 |
ASX - By Stock
|
529
|
180K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
Oz88
|
529 |
180K |
3 |
07/07/21 |
07/07/21 |
ASX - By Stock
|
529
|
180K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: AGM presentation
|
|
Oz88
|
20 |
8.9K |
0 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
20
|
8.9K
|
0
|
|
ASX - By Stock
|
SPX |
Re:
it's just the beginning for Cirralto!
|
|
Oz88
|
20K |
6.0M |
2 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
20K
|
6.0M
|
2
|
|
ASX - By Stock
|
OSP |
Re:
Ann: Strong quarter with milestone distribution agreements signed
|
|
Oz88
|
69 |
15K |
8 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
69
|
15K
|
8
|
|
ASX - By Stock
|
OSP |
Re:
Ann: Strong quarter with milestone distribution agreements signed
|
|
Oz88
|
69 |
15K |
0 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
69
|
15K
|
0
|
|
ASX - By Stock
|
OSP |
Re:
Ann: Strong quarter with milestone distribution agreements signed
|
|
Oz88
|
69 |
15K |
1 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
69
|
15K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C & Quarterly Activity Report
|
|
Oz88
|
68 |
16K |
1 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
68
|
16K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Charting
|
|
Oz88
|
1.7K |
605K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
1.7K
|
605K
|
0
|
|
ASX - By Stock
|
KGN |
Re:
Kogan, really cheap given the growth profile
|
|
Oz88
|
271 |
121K |
0 |
25/10/20 |
25/10/20 |
ASX - By Stock
|
271
|
121K
|
0
|
|
ASX - By Stock
|
SCG |
Re:
Goldman Sachs 12 Month Target Price $3.57
|
|
Oz88
|
7 |
1.7K |
2 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
7
|
1.7K
|
2
|
|
ASX - By Stock
|
SCG |
Re:
$2.50 party
|
|
Oz88
|
163 |
47K |
0 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
163
|
47K
|
0
|
|
ASX - By Stock
|
SCG |
Re:
$2.50 party
|
|
Oz88
|
163 |
47K |
3 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
163
|
47K
|
3
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
0 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
0
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
2
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
2
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
9 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
1 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
213
|
71K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
2 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
213
|
71K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
1 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
213
|
71K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
0 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
213
|
71K
|
0
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
1 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
0 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
213
|
71K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
0 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
213
|
71K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
2 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
213
|
71K
|
2
|
|
ASX - By Stock
|
OAR |
Re:
Ann: Crown Project Update
|
|
Oz88
|
123 |
38K |
9 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
123
|
38K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
2 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
213
|
71K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion announces HREC approval for Phase I study
|
|
Oz88
|
213 |
71K |
3 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
213
|
71K
|
3
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
3 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
3
|
|
ASX - By Stock
|
OAR |
Re:
OAR Predictions
|
|
Oz88
|
1.9K |
681K |
3 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
3
|
|
ASX - By Stock
|
AFG |
Re:
Court decision on Acquisition
|
|
Oz88
|
54 |
19K |
1 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
54
|
19K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Issue of Unlisted Performance Options under EIP
|
|
Oz88
|
39 |
16K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
39
|
16K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Issue of Unlisted Performance Options under EIP
|
|
Oz88
|
39 |
16K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
39
|
16K
|
0
|
|
ASX - By Stock
|
CHK |
Re:
Ann: Horse Well Drilling Update
|
|
Oz88
|
183 |
61K |
6 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
183
|
61K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Issue of Unlisted Performance Options under EIP
|
|
Oz88
|
39 |
16K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
39
|
16K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
11cents next stop.
|
|
Oz88
|
8 |
5.6K |
2 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
8
|
5.6K
|
2
|
|